Document Detail


Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
MedLine Citation:
PMID:  22194486     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: The purpose of this study is to evaluate the performance of gadoxetate disodium-enhanced MRI in the characterization of focal nodular hyperplasia (FNH) and hepatocellular adenoma and to assess potential advantages of hepatocyte phase imaging in identifying features that distinguish FNH from hepatocellular adenoma.
MATERIALS AND METHODS: Gadoxetate disodium-enhanced MRI examinations of 12 patients with hepatocellular adenoma and 35 patients with FNH were retrospectively evaluated by three blinded readers. Diagnoses and confidence scores were recorded before and after disclosure of hepatocyte phase images. The data obtained were combined to create receiver operating characteristic curves, and the areas under the curves were compared. Imaging characteristics, including signal intensity, were recorded. Lesion-to-liver enhancement ratio was calculated for each contrast-enhanced phase.
RESULTS: The readers' average receiver operating characteristic area was significantly higher after disclosure of hepatocyte phase images (p = 0.024). FNHs were correctly diagnosed in 74.3-97.1% of cases before and 97.1-100% of cases after the disclosure of hepatocyte phase images; hepatocellular adenoma was correctly diagnosed in 83-100% and 91.7-100% of cases (p > 0.05). The presence of a central scar in FNH and fat on hepatocellular adenoma were the only morphologic features that were statistically significantly different (p < 0.05). FNH had greater average contrast-enhanced signal intensity and enhancement ratio in all phases (p < 0.001). A hepatocyte phase enhancement ratio of less than 0.7 was 100% specific and 91.6% sensitive for hepatocellular adenoma, with accuracy of 97.1% for these data.
CONCLUSION: Gadoxetate disodium-enhanced MRI had high accuracy in diagnosis of FNH and hepatocellular adenoma, and the hepatocyte phase improved their distinction. FNH enhances significantly more than hepatocellular adenoma. An enhancement ratio, particularly in the hepatocyte phase, can be potentially used as an additional distinguishing feature.
Authors:
Andrei S Purysko; Erick M Remer; Christopher P Coppa; Nancy A Obuchowski; Erika Schneider; Joseph C Veniero
Related Documents :
21587186 - Computed tomography dose index and dose length product for cone-beam ct: monte carlo si...
17005766 - A prospective comparative study of narrow-band imaging, chromoendoscopy, and convention...
12612816 - Assessment of image quality of a standard and two dose-reducing protocols in paediatric...
14624156 - Computed tomography colonography in routine clinical practice.
19862676 - Atypical mycobacterial tenosynovitis and bursitis of the wrist.
15234456 - Ex vivo proton mr spectroscopy (1h-mrs) for evaluation of human gastric carcinoma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  AJR. American journal of roentgenology     Volume:  198     ISSN:  1546-3141     ISO Abbreviation:  AJR Am J Roentgenol     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2011-12-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7708173     Medline TA:  AJR Am J Roentgenol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  115-23     Citation Subset:  AIM; IM    
Affiliation:
Section of Abdominal Imaging, The Cleveland Clinic Foundation, Cleveland Clinic Main Campus, 9500 Euclid Ave, A21, Cleveland, OH 44195.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy of Fusion Imaging Combining Sonography and Hepatobiliary Phase MRI With Gd-EOB-DTPA to Dete...
Next Document:  Secretin-Enhanced MRCP: Review of Technique and Application With Proposal for Quantification of Exoc...